Phase III Clinical Trial of SHPL-49 Injection in the Treatment of Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Conditions

Acute Ischemic Stroke

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Linfen Central Hospital, Linfen, Shanxi, China
Contact: Study coordinator (Hongguo Dai, Master) · daihongguo3199@163.com · 86-15935767592

Study leads

Yongjun Wang, Master
Principal Investigator
Beijing Tiantan Hospital

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Tenecteplase for Intravenous Stroke Thrombolysis in Recent DOAC Users

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Guangzhou, China

Phase III Clinical Trial of rhTNK-tPA in Treating Acute Ischemic Stroke With Extended Time Window.

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE3

Puyang, China

A Study of TAK-755 in Adults With Acute Ischemic Stroke

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Scottsdale, United States

Efficacy and Safety of the KPCXM18 Injection in Patients With Acute Ischemic Stroke

Acute Ischemic Stroke

Abroad (travel likely)RecruitingPHASE2

Beijing, China · Shenzhen, China